The CADTH Canadian Drug Expert Committee has recommended that ticagrelor be reimbursed when co-administered with low-dose (75 mg to 150 mg) aspirin for the secondary prevention of atherothrombotic events in patients with a recent history of myocardial infarction and a high risk of developing an atherothrombotic event, so long as certain condition and criteria are met.

One of the many conditions is a reduced price.

Read CADTH recommendation for Brilinta